Characterization of acute and long-term pathologies of superficial and deep dermal sulfur mustard skin lesions in the hairless guinea pig model

Wound Repair and Regeneration

Volumn 20, Issue 6, 2012, Pages 852-853

  Dachir, Shlomit ^a   Cohen, Maayan ^a   Kamus Elimeleh, Dikla ^a   Fishbine, Eliezer ^a   Sahar, Rita ^a   Gez, Rellie ^a   Brandeis, Rachel ^a   Horwitz, Vered ^a   Kadar, Tamar ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MUSTARD GAS; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORIMETRY; DERMIS; EDEMA; ENZYME ACTIVITY; EPIDERMIS; EPIDERMIS HYPERPLASIA; ERYTHEMA; EXPERIMENTAL GUINEA PIG; HAIR FOLLICLE; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; SKIN INJURY; STRATUM CORNEUM; WOUND ASSESSMENT; WOUND HEALING;

EID: 84868574507     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00830.x     Document Type: Article

References (43)

1. Willems JL,. Clinical management of mustard gas casualties. Anna Med Militaris 1989; 3 (Suppl): 1-61.
2. Mellor SG, Rice P, Cooper GJ,. Vesicant burns. Br J Plast Surg 1991; 44: 434-437.
3. Thomsen AB, Erisken J, Smidt-Nielsen K,. Chronic neuropathic symptoms after exposure to mustard gas: a long-term investigation. J Am Acad Dermatol 1998; 39: 187-190.
4. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali I, Attaran D, Maleki M, Razavi MRE, Zare G, Jaafari MR, Tabatabaee A,. Evaluation of delayed toxic effects of sulfur mustard poisoning in severely intoxicated Iranian veterans: a cross-sectional study. J Med CBR Def 2005; 3: 1-32.
5. Shohrati M, Davoudi M, Ghanei M,. Cutaneous and ocular late complications of sulfur mustard in Iranian veterans. Cutan Ocul Toxicol 2007; 26: 73-81.
6. Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Thiermann H,. Sulfur mustard researchâstrategies for the development of improved medical therapy. ePlasty 2008; 8: 312-332.
7. Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM, Aghamiri SS,. Mustard gas scarring with specific pigmentary, trophic and vascular characteristic (case report, 16-year post-exposure). Ecotoxicol Environ Saf 2008; 69: 574-576.
8. Rowell M, Kehe K, Balszuweit F, Thiermann H,. The chronic effects of sulfur mustard exposure. Toxicology 2009; 263: 9-11.
9. Balali-Mood M, Hefazi M,. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Pharmacol Toxicol 2006; 99: 273-282.
10. Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR,. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 1995; 32: 765-776.
11. Dachir S, Cohen M, Fishbeine E, Sahar R, Brandies R, Horwitz V, Kadar T,. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods. Skin Res Technol 2010; 16: 114-124.
12. Braue EH Jr, Koplovitz I, Mitcheltree LW, Clayson ET, Litchfield MR, Bangledorf CR,. Characterization of the sulfur mustard vapor induced cutaneous lesions on hairless guinea pigs. Toxicol Mech Methods 1992; 2: 242-254.
13. Kehe K, Szinicz L,. Medical aspects of sulphur mustard poisoning. Toxicology 2005; 214: 198-209.
14. Benson JM, Seagrave JC, Weber WM, Santistevan CD, Grotendorst GR, Schultz GS, March TH,. Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury. Wound Rep Reg 2011; 19: 348-357.
15. Le HE, Knudsen SJ,. Exposure to a First World War blistering agent. Emerg Med J 2006; 23: 296-299.
16. Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M,. Skin manifestations of mustard gas. Arch Dermatol 1992; 128: 775-780.
17. Papirmeister B, Feister AJ, Robinson SI, Ford RD,. The sulfur mustard injury: description of lesions and resulting incapacitation. In:, Papirmeister B, editor. Medical defense against mustard gas: toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press Inc., 1991: 13-34.
18. Sohrabpour H,. Observation and clinical manifestations of patients injured with mustard gas. Med J Islam Rep Iran 1987; 1: 32-37.
19. Mershon MM, Mitcheltree LW, Petrali JP, Braue EH, Wade JV,. Hairless guinea pig bioassay model for vesicant vapor exposures. Fund Appl Toxicol 1990; 15: 622-630.
20. Snider TH, Matthews MC, Braue EH Jr,. Model for assessing efficacy of topical skin protectants against sulfur mustard vapor using hairless guinea pigs. J Appl Toxicol 1999; 19: S55-58.
21. Yourick JJ, Dawson JS, Mitcheltree LW,. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J Appl Toxicol 1995; 15: 133-138.
22. Dachir S, Fishbeine E, Meshulam Y, Sahar R, Amir A, Kadar T,. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum Exp Toxicol 2002; 21: 197-203.
23. Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH Jr, Squibb KS,. Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res Technol 2002; 8: 57-69.
24. Davoudi SM, Keshavarz S, Sadr B, Shohrati M, Naghizadeh MM, Farsinejad K, Rashighi-Firouzabadi M, Zartab H, Firooz A,. Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study. J Eur Acad Dermatol Venereol 2009; 23: 940-944.
25. Allon A, Amir A, Manisterski E, Rabinovitz I, Dachir S, Kadar T,. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicol Appl Pharmacol 2009; 241: 154-162.
26. Barranco VP,. Mustard gas and the dermatologist. Int J Dermatol 1991; 30: 684-686.
27. Cowan FM, Broomfield CA,. Putative role of inflammation in the dermatopathology of sulfur mustard. Cell Biol Toxicol 1993; 9: 201-213.
28. Dachir S, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Amir A, Kadar T,. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J Appl Toxicol 2004; 24: 107-113.
29. Joseph LB, Gerecke DR, Heck DE, Black AT, Sinko PJ, Cervelli JA, Casillas RP, Babin MC, Laskin DL, Laskin JD,. Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage. Exp Mol Pathol 2011; 91: 515-527.
30. Kadar T, Dachir S, Cohen L, Sahar R, Fishbine E, Cohen M, Turetz J, Gutman H, Buch H, Brandeis R, Horwitz V, Solomon A, Amir A,. Ocular injuries following sulfur mustard exposureâpathological mechanism and potential therapy. Toxicology 2009; 263: 59-69.
31. Malaviya R, Sunil VR, Cervelli J, Anderson DR, Holmes WW, Conti ML, Gordon RE, Laskin JD, Laskin DL,. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol Appl Pharmacol 2010; 248: 89-99.
32. Black AT, Joseph LB, Casillas RP, Heck DE, Gerecke DR, Sinko PJ, Laskin DL, Laskin JD,. Role of MAP kinases in regulating expression of antioxidant and inflammatory mediators in mouse keratinocytes following exposure to the half mustard, 2-chloroethyl ethyl sulfide. Toxicol Appl Pharmacol 2010; 245: 352-360.
33. Black AT, Hayden PJ, Casillas RP, Heck DE, Gerecke DR, Sinko PJ, Laskin DL, Laskin JD,. Expression of proliferative and inflammatory markers in a full -thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Toxicol Appl Pharmacol 2010; 249: 178-187.
34. Nyska A, Lomnitski L, Maronpot R, Moomaw C, Brodsky B, Sintov A, Wormser U,. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin injury in guinea pigs. Arch Toxicol 2001; 74: 768-774.
35. Amir A, Turetz J, Chapman S, Fishbeine E, Meshulam J, Sahar R, Liani H, Gilat E, Frishman G, Kadar T,. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J Appl Toxicol 2000; 20 (Suppl 1): S109-114.
36. Jain AK, Tewari-Singh N, Gu M, Inturi S, White CW, Agarwal R,. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin. Toxicol Lett 2011; 205: 293-301.
37. Mol MAE, van den Berg RM, Benschop HP,. Involvement of caspases and transmembrane metalloproteases in sulphur mustard-induced microvesication in adult human skin in organ culture: directions for therapy. Toxicology 2009; 258: 39-46.
38. Ries C, Popp T, Egea V, Kehe K, Jochum M,. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: upregulation response to sulphur mustard. Toxicology 2009; 263: 26-31.
39. Sabourin CLK, Danne MM, Buxton KL, Casillas RP, Schlager JJ,. Cytokine, chemokine and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002; 16: 263-272.
40. Shakarjian MP, Bhatt P, Gordon MK, Chang YC, Casbohm SL, Rudge TL, Kiser RC, Sabourin CL, Casillas RP, Ohman-Stricklan P, Riley DJ, Gerecke DR,. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J Appl Toxicol 2006; 26: 239-246.
41. Sueki H, Gammal C, Kudoh K, Kligman AM,. Hairless guinea pig skin: anatomical basis for studies of cutaneous biology. Eur J Dermatol 2000; 10: 357-364.
42. Sueki H, Kligman AM,. Cutaneous toxicity of chemical irritants on hairless guinea pigs. J Dermatol 2003; 30: 859-870.
43. Smith KJ, Graham JS, Skelton HG, O'Leary T, Moeller RB, Okerberg CV, Hurst CG,. Evaluation of cross-reacting anti-human antibodies in the euthymic hairless guinea pig model (HGP) suggests that the HGP may be a model for the study of proliferative skin disease. J Dermatol Sci 1997; 14: 240-250.